18F-labeled fluorodeoxyglucose for PET imaging: The working mechanism and its clinical implication

Drugs of the Future

Volumn 26, Issue 7, 2001, Pages 659-668

  Pauwels, E K J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; FRUCTOSE 6 PHOSPHATE; GLUCOSE TRANSPORTER; HEXOKINASE; MESSENGER RNA; PROTEIN P53;

CELL MEMBRANE; CITRIC ACID CYCLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BINDING; GENE AMPLIFICATION; GENE EXPRESSION; GLUCOSE TRANSPORT; GLYCOLYSIS; HUMAN; HUMAN CELL; IMAGING; POSITRON EMISSION TOMOGRAPHY; REVIEW; TUMOR CELL;

EID: 0034768552     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2001.026.07.858710     Document Type: Review

References (81)

1. +/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose
2. +/glucose cotransporter cloned from rabbit small intestine
3. Human facilitative glucose transporters. Isolation, functional characterization, and gene localization of cDNAs encoding an isoform (GLUT5) expressed in small intestine, kidney, muscle, and adipose tissue and an unusual glucose transporter pseudogene-like sequence (GLUT6)
4. Cloning and expression of a hepatic microsomal glucose transport protein. Comparison with liver plasma-membrane glucosetransport protein GLUT 2
5. Expression and localization of glucose transporter 1 (GLUT1) in the rat oviduct: A possible supplier of glucose to embryo during early embryonic development
6. Quantitation and immunolocalization of glucose transporters in the human placenta
7. The role of insulin in activation of two enhancers in the mouse GLUT1 gene
8. Regulation of cell surface GLUT1, GLUT3, and GLUT4 by insulin and IGF-I in L6 myotubes
9. Differential regulation of two glucose transporters by chronic growth hormone treatment of cultured 3T3-F442A adipose cells
10. Glucose transport stimulation by thyroid hormone in ARL 15 cells: Partial role of increased GLUT1 glucose transporter gene transcription
11. Facilitative glucose transporters
12. Immunolocalization of GLUT1 and GLUT3 glucose transporters in primary cultured neurons and glia
13. Facilitated diffusion of glucose
14. Cellular stress causes accumulation of the glucose transporter at the surface of cells independently of their insulin sensitivity
15. Liver glucose transporter: A basolateral protein in hepatocytes and intestine and kidney cells
16. Glucose transporter 2 (GLUT2): Expression in specific brain nuclei
17. Analysis of upstream glucokinase promoter activity in transgenic mice and identification of glucokinase in rare neuroendocrine cells in the brain and gut
18. Cloning and functional expression in bacteria of a novel glucose transporter present in liver, intestine, kidney, and beta-pancreatic islet cells
19. Substrate specificity and kinetic parameters of GLUT3 in rat cerebellar granule neurons
20. Tissue distribution of the human GLUT3 glucose transporter
21. Moving GLUT4: The biogenesis and trafficking of GLUT4 storage vesicles
22. From receptor to transporter: Insulin signalling to glucose transport
23. Jejunal/kidney glucose transporter isoform (Glut-5) is expressed in the human blood-brain barrier
24. Characterization of the rabbit intestinal fructose transporter (GLUT5)
25. Mammalian passive glucose transporters: Members of an ubiquitous family of active and passive transport proteins
26. Proteins that interact with facilitative glucose transporters: Implication for function
27. Hexokinase binding to mitochondria: A basis for proliferative energy metabolism
28. Differences in expression and intracellular distribution of hexokinase isoenzymes in rat liver cells of different transformation stages
29. Growth factors, mitogens, oncogenes and the regulation of glucose transport
30. Sugar-dependent expression of the fructose transporter GLUT5 in Caco-2 cells
31. Over-expression of facilitative glucose transporter genes in human cancer
32. Distribution of the glucose transporters in human brain tumors
33. Expression of glucose transporters in head-and-neck tumors
34. Immunohistochemical localization of glucose transporters in human renal cell carcinoma
35. Glucose transporter proteins in human insulinoma
36. High expression of the Glut1 glucose transporter in human brain hemangioblastoma endothelium
37. GLUT1 glucose transporter expression in benign and malignant thyroid nodules
38. Overexpression of Glut1 and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival
39. Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study
40. Expression of the fructose transporter GLUT5 in human breast cancer
41. Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers
42. 3H-2-deoxyglucose retention in murine tumor models
43. Expression of facilitative glucose transport proteins during development of squamous cell carcinomas of the head and neck
44. Polarity of transport of 2-deoxy-D-glucose and D-glucose by cultured renal epithelia (LLC-PK1)
45. 31P nuclear magnetic resonance spectroscopy
46. D-19575-a sugar-linked isophosphoramide mustard derivative exploiting transmembrane glucose transport
47. Contributions of glycolysis and oxidative phosphorylation to adenosine 5′triphosphate production in AS-30D hepatoma cells
48. Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes
49. Transformation of rat fibroblasts by FSV rapidly increases glucose transporter gene transcription
50. Alterations in glucose metabolism in chick embryo cells transformed by Rous sarcoma virus. Transformation-specific changes in the activities of key enzymes of the glycolytic and hexose monophosphate shunt pathways
51. Functional significance of mitochondrial bound hexokinase in tumor cell metabolism. Evidence for preferential phosphorylation of glucose by intramitochondrially generated ATP
52. Structure/function relationships in hexokinase. Site-directed mutational analyses and characterization of overexpressed fragments implicate different functions for the N- and C-terminal halves of the enzyme
53. High aerobic glycolysis of rat hepatoma cells in culture: Role of mitochondrial hexokinase
54. Glucose catabolism in cancer cells. Isolation, sequence, and activity of the promoter for type II hexokinase
55. Protein kinase activity of rat brain hexokinase
56. Glucose utilization by tumor cells: The enzyme hexokinase autophosphorylates both its N- and C-terminal halves
57. Evidence that transcription of the hexokinase gene is increased in a rapidly growing rat hepatoma
58. Mammalian glucokinase
59. The genes of hepatic glucose metabolism
60. Purification and characterization of hypoxia-inducible factor 1
61. Glucose catabolism in cancer cells: Regulation of the type II hexokinase promoter by glucose and cyclic AMP
62. Glucose catabolism in cancer cells. The type II hexokinase promoter contains functionally active response elements for the tumor suppressor p53
63. Fluorodeoxyglucose (FDG) and tumour metabolism
64. F-18 fluorodeoxyglucose chest uptake in lung inflammation and infection
65. Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology?
66. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose
67. Primary and metastatic breast carcinoma: Initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose
68. Serum glucose: Effects on tumor and normal tissue accumulation of 2-[F-18]-fluoro-2deoxy-D-glucose in rodents with mammary carcinoma
69. Glucose regulates glut 1 function and expression in fetal rat lung and muscle in vitro
70. Effect of hyperglycemia on in vitro tumor uptake of tritiated FDG, thymidine, L-methionine and L-leucine
71. The applications of PET in clinical oncology
72. Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: Characterization of tumor and assessment of effect of treatment
73. Fluorodeoxyglucose cell incorporation as an index of cell proliferation: Evaluation of accuracy in cell culture
74. 18F]-fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: A preliminary observation
75. Fluorodeoxyglucose imaging: A method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors
76. Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake
77. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: High accumulation in macrophages and granulation tissues studied by microautoradiography
78. Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake
79. PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy
80. Regulation of glucose-transporter function